You are here:

MS in the Media - 10 May 2019

Published on

On this page

  1. Ocrevus approved for PPMS
  2. Lack of services for people with advanced MS
  3. Fasting diet helps MS symptoms

4 - 10 May 2019

These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.

Ocrevus approved for PPMS

The first disease modifying drug for people with primary progressive MS in England has been approved by NICE.  Ocrevus (ocrelizumab) will be available for prescription for people with early, inflammatory primary progressive MS. Talks are underway about availability in the rest of the UK. 

Source: BBC
Source: Daily Telegraph
Source: Pharmaphorum

MS Trust link: Good news! NICE approves Ocrevus (ocrelizumab) for primary progressive MS (includes the eligibility criteria for the drug)

Lack of services for people with advanced MS

David Martin of the MS Trust talks about the injustice of the two tier system for people with MS, where people who are eligible for a disease modifying drug are more likely to get a good service than those who aren't.  He discussed the Advance MS Champions project that is trying to start to address this problem

Source: Pharmaphorum

MS Trust link: Advanced MS Champions

Fasting diet helps MS symptoms

Following a high-fat, low-carbohydrate ketogenic diet, which mimics fasting, was associated with improvements in fatigue and depression in people with MS, according to a small US study

Source: National MS Society (USA)

MS Trust link: Diet

Print this page